FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126519881> ?p ?o ?g. }

• W2126519881 endingPage "1268" @default.
• W2126519881 startingPage "1263" @default.
• W2126519881 abstract "Background The initial experience with continuous positive airway pressure (CPAP) may predict subsequent compliance. In a retrospective study, we found that premedication with nonbenzodiazepine sedative-hypnotic agents during CPAP titration polysomnography independently predicted short-term compliance. To validate these findings, we conducted a prospective clinical trial to assess whether premedication with eszopiclone prior to CPAP titration would improve short-term CPAP compliance. Methods Subjects in this randomized, double-blind, placebo-controlled trial received 3 mg of eszopiclone or matching placebo prior to undergoing CPAP titration polysomnography. We compared the quality of CPAP titrations and objective measures of compliance during the first 4 to 6 weeks of therapy between the two groups. Results We enrolled 117 subjects, and 98 subjects completed the protocol (eszopiclone, 50 subjects; placebo, 48 subjects). Other than there being more women in the eszopiclone group, the groups were similar at baseline. Compared with placebo, premedication with eszopiclone significantly improved mean (± SD) sleep efficiency (87.8 ± 5.8% vs 80.1 ± 10.5%, respectively; p = 0.002) and mean total sleep time (350.9 ± 33.6 min vs 319.7 ± 48.7 min, respectively; p = 0.007). A trend toward improved sleep latency (19.4 ± 16.1 min vs 31.8 ± 30.4 min, respectively; p = 0.08) and the number of residual obstructive events observed at the final CPAP pressure (6.4 ± 7 events/h vs 12.8 ± 14.6 events/h, respectively; p = 0.08) during polysomnography was found. Eszopiclone significantly improved CPAP compliance. Among subjects premedicated with eszopiclone, CPAP was used on a higher percentage of nights (75.9 ± 20.0% vs 60.1 ± 24.3%, respectively; p = 0.005) and for more hours per night (4.8 ± 1.5 h vs 3.9 ± 1.8 h, respectively; p = 0.03). Conclusions Premedication with eszopiclone on the night of CPAP titration improved the quality of CPAP titration and led to significantly greater short-term compliance. Trial registration ClinicalTrials.gov Identifier: NCT00507117 The initial experience with continuous positive airway pressure (CPAP) may predict subsequent compliance. In a retrospective study, we found that premedication with nonbenzodiazepine sedative-hypnotic agents during CPAP titration polysomnography independently predicted short-term compliance. To validate these findings, we conducted a prospective clinical trial to assess whether premedication with eszopiclone prior to CPAP titration would improve short-term CPAP compliance. Subjects in this randomized, double-blind, placebo-controlled trial received 3 mg of eszopiclone or matching placebo prior to undergoing CPAP titration polysomnography. We compared the quality of CPAP titrations and objective measures of compliance during the first 4 to 6 weeks of therapy between the two groups. We enrolled 117 subjects, and 98 subjects completed the protocol (eszopiclone, 50 subjects; placebo, 48 subjects). Other than there being more women in the eszopiclone group, the groups were similar at baseline. Compared with placebo, premedication with eszopiclone significantly improved mean (± SD) sleep efficiency (87.8 ± 5.8% vs 80.1 ± 10.5%, respectively; p = 0.002) and mean total sleep time (350.9 ± 33.6 min vs 319.7 ± 48.7 min, respectively; p = 0.007). A trend toward improved sleep latency (19.4 ± 16.1 min vs 31.8 ± 30.4 min, respectively; p = 0.08) and the number of residual obstructive events observed at the final CPAP pressure (6.4 ± 7 events/h vs 12.8 ± 14.6 events/h, respectively; p = 0.08) during polysomnography was found. Eszopiclone significantly improved CPAP compliance. Among subjects premedicated with eszopiclone, CPAP was used on a higher percentage of nights (75.9 ± 20.0% vs 60.1 ± 24.3%, respectively; p = 0.005) and for more hours per night (4.8 ± 1.5 h vs 3.9 ± 1.8 h, respectively; p = 0.03). Premedication with eszopiclone on the night of CPAP titration improved the quality of CPAP titration and led to significantly greater short-term compliance." @default.
• W2126519881 created "2016-06-24" @default.
• W2126519881 creator A5021355817 @default.
• W2126519881 creator A5039918413 @default.
• W2126519881 creator A5069248842 @default.
• W2126519881 creator A5091723507 @default.
• W2126519881 date "2009-11-01" @default.
• W2126519881 modified "2023-10-07" @default.
• W2126519881 title "Sedative Use During Continuous Positive Airway Pressure Titration Improves Subsequent Compliance" @default.
• W2126519881 cites W103211649 @default.
• W2126519881 cites W104120026 @default.
• W2126519881 cites W197066864 @default.
• W2126519881 cites W1973054827 @default.
• W2126519881 cites W1988087271 @default.
• W2126519881 cites W199255092 @default.
• W2126519881 cites W2008953362 @default.
• W2126519881 cites W2031374244 @default.
• W2126519881 cites W2032233607 @default.
• W2126519881 cites W2040705431 @default.
• W2126519881 cites W2056722705 @default.
• W2126519881 cites W2070619672 @default.
• W2126519881 cites W2082533403 @default.
• W2126519881 cites W2093737681 @default.
• W2126519881 cites W2124052130 @default.
• W2126519881 cites W2135258117 @default.
• W2126519881 cites W2136167986 @default.
• W2126519881 cites W2137272432 @default.
• W2126519881 cites W2139704316 @default.
• W2126519881 cites W2144194006 @default.
• W2126519881 cites W2165404677 @default.
• W2126519881 cites W2403819081 @default.
• W2126519881 cites W2730034759 @default.
• W2126519881 cites W70729089 @default.
• W2126519881 doi "https://doi.org/10.1378/chest.09-0811" @default.
• W2126519881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19567493" @default.
• W2126519881 hasPublicationYear "2009" @default.
• W2126519881 type Work @default.
• W2126519881 sameAs 2126519881 @default.
• W2126519881 citedByCount "57" @default.
• W2126519881 countsByYear W21265198812012 @default.
• W2126519881 countsByYear W21265198812013 @default.
• W2126519881 countsByYear W21265198812014 @default.
• W2126519881 countsByYear W21265198812015 @default.
• W2126519881 countsByYear W21265198812016 @default.
• W2126519881 countsByYear W21265198812017 @default.
• W2126519881 countsByYear W21265198812018 @default.
• W2126519881 countsByYear W21265198812019 @default.
• W2126519881 countsByYear W21265198812020 @default.
• W2126519881 countsByYear W21265198812021 @default.
• W2126519881 countsByYear W21265198812022 @default.
• W2126519881 crossrefType "journal-article" @default.
• W2126519881 hasAuthorship W2126519881A5021355817 @default.
• W2126519881 hasAuthorship W2126519881A5039918413 @default.
• W2126519881 hasAuthorship W2126519881A5069248842 @default.
• W2126519881 hasAuthorship W2126519881A5091723507 @default.
• W2126519881 hasBestOaLocation W21265198811 @default.
• W2126519881 hasConcept C142724271 @default.
• W2126519881 hasConcept C204787440 @default.
• W2126519881 hasConcept C27081682 @default.
• W2126519881 hasConcept C2776006263 @default.
• W2126519881 hasConcept C2777602617 @default.
• W2126519881 hasConcept C2778205975 @default.
• W2126519881 hasConcept C2778300832 @default.
• W2126519881 hasConcept C2779547634 @default.
• W2126519881 hasConcept C2781326671 @default.
• W2126519881 hasConcept C42219234 @default.
• W2126519881 hasConcept C71924100 @default.
• W2126519881 hasConceptScore W2126519881C142724271 @default.
• W2126519881 hasConceptScore W2126519881C204787440 @default.
• W2126519881 hasConceptScore W2126519881C27081682 @default.
• W2126519881 hasConceptScore W2126519881C2776006263 @default.
• W2126519881 hasConceptScore W2126519881C2777602617 @default.
• W2126519881 hasConceptScore W2126519881C2778205975 @default.
• W2126519881 hasConceptScore W2126519881C2778300832 @default.
• W2126519881 hasConceptScore W2126519881C2779547634 @default.
• W2126519881 hasConceptScore W2126519881C2781326671 @default.
• W2126519881 hasConceptScore W2126519881C42219234 @default.
• W2126519881 hasConceptScore W2126519881C71924100 @default.
• W2126519881 hasIssue "5" @default.
• W2126519881 hasLocation W21265198811 @default.
• W2126519881 hasLocation W21265198812 @default.
• W2126519881 hasOpenAccess W2126519881 @default.
• W2126519881 hasPrimaryLocation W21265198811 @default.
• W2126519881 hasRelatedWork W2010494850 @default.
• W2126519881 hasRelatedWork W2023033489 @default.
• W2126519881 hasRelatedWork W2034478411 @default.
• W2126519881 hasRelatedWork W2113982368 @default.
• W2126519881 hasRelatedWork W2135378166 @default.
• W2126519881 hasRelatedWork W2166916384 @default.
• W2126519881 hasRelatedWork W2409033918 @default.
• W2126519881 hasRelatedWork W2416547506 @default.
• W2126519881 hasRelatedWork W2436918163 @default.
• W2126519881 hasRelatedWork W4248015327 @default.
• W2126519881 hasVolume "136" @default.
• W2126519881 isParatext "false" @default.
• W2126519881 isRetracted "false" @default.
• W2126519881 magId "2126519881" @default.
• W2126519881 workType "article" @default.